1558037-97-0

Basic information

• Product Name: 6-(toluenesulfonyloxy)-2-azaspiro[3.3]heptane-2-carboxylic acid tert-butyl ester
• Synonyms: 6-(toluenesulfonyloxy)-2-azaspiro[3.3]heptane-2-carboxylic acid tert-butyl ester
• CAS NO: 1558037-97-0
• Molecular Weight: 367.466
• Mol File: 1558037-97-0.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: 6-(toluenesulfonyloxy)-2-azaspiro[3.3]heptane-2-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(toluenesulfonyloxy)-2-azaspiro[3.3]heptane-2-carboxylic acid tert-butyl ester(1558037-97-0)
• EPA Substance Registry System: 6-(toluenesulfonyloxy)-2-azaspiro[3.3]heptane-2-carboxylic acid tert-butyl ester(1558037-97-0)

Safety Data

• Hazardous Substances Data: 1558037-97-0(Hazardous Substances Data)

Upstream product

• 1181816-12-5 6-oxo-2-aza-spiro[3.3]heptane-2-carboxylic acid tert-butyl ester 
• 1147557-97-8 6-hydroxy-2-aza-spiro[3.3]heptane-2-carboxylic acid tert-butyl ester 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 1558038-16-6 C₂₇H₃₀N₄O₄ 
• 1558038-17-7 C₂₂H₂₂N₄O₂ 
• 1558038-33-7 C₂₉H₃₂N₂O₅S 
• 1558038-41-7 C₂₂H₂₃N₅O₂ 
• 1558036-56-8 C₂₅H₂₄N₄O₃ 
• 1558036-89-7 C₂₆H₂₃N₃O₃S 
• 1558037-08-3 C₃₀H₃₄N₆O₄ 
• 1558036-72-8 C₂₆H₂₅N₅O₃ 
• 1558038-59-7 C₂₁H₂₂N₆O₂ 
• 1558037-32-3 C₂₄H₂₄N₆O₃ 
• 1558038-65-5 C₁₉H₂₅N₅O₂ 
• 1558037-36-7 C₂₂H₂₇N₅O₃ 
• 1558038-06-4 C₂₉H₃₃N₃O₅ 
• 1558038-40-6 C₂₇H₂₉N₅O₃ 

Relevant articles and documents

Pyrimidine compounds and their uses

The present invention proposes pyrimidine compounds and their uses, in particular, the present invention proposes a new compound that effectively inhibits ATX, which is a compound shown in the formula below, or a tautomer of the compound of the following

PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS

The present application provides a compound of formula (I) or a stereoisomer thereof, or an atropisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of a stereoisomer thereof, or a pharmaceutically acceptable salt of an atropisomer thereof; method for manufacturing said compound, and its therapeutic uses. The present application further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.

Compound serving as IRARAK inhibitor as well as preparation method and application thereof (by machine translation)

The present invention relates to compounds useful for treating cancer and inflammatory diseases associated with interleukin -1 receptor-related kinases (IRARAK), in particular compounds shown as IRARARARAK-4 inhibitors, stereoisomers thereof, racemates, t